Acadia Pharmaceuticals | ACAD - Créances Commerciales

Prix De L'Action
20.74
Variation Quotidienne
0.02 0.10%
Mensuellement
-16.13%
Annuel
23.53%
Q1 Prévisions
20.12




Créances Commerciales Changement Date
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
ALKERMES USD 334.02M 21.08M 2025-12
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Biogen USD 1.85B 234M 2025-09
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Cara Therapeutics USD 2.24M 2.26M 2025-03
Corcept Therapeutics USD 59.79M 9.84M 2025-12
Cytokinetics USD 1.81M 6.6M 2025-09
Eisai JPY 249.06B 25B 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Incyte USD 1.02B 128.52M 2025-12
J&J USD 17.61B 235M 2025-09
Moderna USD 184M 862M 2025-12
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Prothena USD 5.16M 0 2023-12
PTC Therapeutics USD 181.62M 21.45M 2025-12
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12